Benjamin Lockshin, MD

Director of Clinical Trial Center
US Dermatology Partners

Poster(s):

• (103) Efficacy and safety of roflumilast foam 0.3% in patients with psoriasis of the scalp and body in the phase 3 ARRECTOR trial
  Wednesday, October 29, 2025